Compare PFSI & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PFSI | BCPC |
|---|---|---|
| Founded | 2008 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.4B |
| IPO Year | 2018 | 1995 |
| Metric | PFSI | BCPC |
|---|---|---|
| Price | $91.28 | $174.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | $131.63 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 529.4K | 157.0K |
| Earning Date | 04-21-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.31% | 0.55% |
| EPS Growth | ★ 59.25 | 20.87 |
| EPS | ★ 9.30 | 4.75 |
| Revenue | ★ $984,629,000.00 | $799,023,000.00 |
| Revenue This Year | N/A | $8.47 |
| Revenue Next Year | $16.02 | $4.89 |
| P/E Ratio | ★ $9.86 | $36.85 |
| Revenue Growth | 3.05 | ★ 13.56 |
| 52 Week Low | $82.65 | $139.17 |
| 52 Week High | $160.36 | $183.90 |
| Indicator | PFSI | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 51.91 | 58.63 |
| Support Level | $88.57 | $153.51 |
| Resistance Level | $104.38 | $183.45 |
| Average True Range (ATR) | 2.49 | 3.65 |
| MACD | 1.31 | 1.02 |
| Stochastic Oscillator | 78.01 | 84.24 |
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.